Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. January 6-7, 1994.

[No authors listed]

J Am Coll Cardiol. 1994 Oct;24(4):845-99. No abstract available. Erratum in: Med Sci Sports Exerc 1994 Dec;26(12):followi.

2.
3.

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 4: systemic hypertension.

Kaplan NM, Deveraux RB, Miller HS Jr.

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S268-70. Review. No abstract available.

PMID:
7934750
6.

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 5: coronary artery disease.

Thompson PD, Klocke FJ, Levine BD, Van Camp SP.

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S271-5. Review. No abstract available.

PMID:
7934751
7.

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 5: coronary artery disease.

Thompson PD, Klocke FJ, Levine BD, Van Camp SP.

J Am Coll Cardiol. 1994 Oct;24(4):888-92. Review. No abstract available.

8.

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease.

Graham TP Jr, Bricker JT, James FW, Strong WB.

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S246-53. Review. No abstract available.

PMID:
7934747
9.

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease.

Graham TP Jr, Bricker JT, James FW, Strong WB.

J Am Coll Cardiol. 1994 Oct;24(4):867-73. Review. No abstract available.

10.

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 6: arrhythmias.

Zipes DP, Garson A Jr.

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S276-83. Review. No abstract available.

PMID:
7523824
11.
12.

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.

Cheitlin MD, Douglas PS, Parmley WW.

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S254-60. Review. No abstract available.

PMID:
7934748
13.
14.

Cardiovascular disease in athletes.

Vasamreddy CR, Ahmed D, Gluckman TJ, Blumenthal RS.

Clin Sports Med. 2004 Jul;23(3):455-71, x. Review.

PMID:
15262382
15.
17.

Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.

Maron BJ, Chaitman BR, Ackerman MJ, Bayés de Luna A, Corrado D, Crosson JE, Deal BJ, Driscoll DJ, Estes NA 3rd, Araújo CG, Liang DH, Mitten MJ, Myerburg RJ, Pelliccia A, Thompson PD, Towbin JA, Van Camp SP; Working Groups of the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention; Councils on Clinical Cardiology and Cardiovascular Disease in the Young.

Circulation. 2004 Jun 8;109(22):2807-16. Review.

18.

[The cardiovascular system and sports].

Medved R, Duraković Z, Misigoj-Duraković M.

Lijec Vjesn. 1998 Jul-Aug;120(7-8):228-36. Review. Croatian.

PMID:
9919882
19.

Hypertrophic cardiomyopathy: who plays and who sits.

Rizvi AA, Thompson PD.

Curr Sports Med Rep. 2002 Apr;1(2):93-9. Review.

PMID:
12831717
20.

Revised eligibility recommendations for competitive athletes with cardiovascular abnormalities.

Maron BJ, Mitchell JH.

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S223-6. Review. No abstract available.

PMID:
7934742

Supplemental Content

Support Center